BamSEC and AlphaSense Join Forces
Learn More

Arrowhead Pharmaceuticals Inc. – Underwriting Agreements

NASDAQ: ARWR    
Share price (6/8/26): $73.86    
Market cap (6/8/26): $10.4 billion
Search in Documents
Key Exhibits
External Links

Underwriting Agreements Filter

EX-1.2
from 8-K 49 pages $625,000,000 0% Convertible Senior Notes Due 2032 Arrowhead Pharmaceuticals, Inc. Underwriting Agreement
12/34/56
EX-1.1
from 8-K 48 pages 1,550,389 Shares Pre-Funded Warrants to Purchase 1,550,387 Shares Arrowhead Pharmaceuticals, Inc. Underwriting Agreement
12/34/56
EX-1.2
from S-3ASR 40 pages Amended and Restated Open Market Sale Agreementsm
12/34/56
EX-1
from SC 13G 1 page Exhibit 1 Joint Filing Agreement Pursuant to Rule 13d-1
12/34/56
EX-1.1
from 8-K 44 pages Underwriting agreement
12/34/56
EX-1.1
from 8-K 35 pages Open Market Sale Agreement1
12/34/56
EX-1.2
from S-3ASR 39 pages Open Market Sale Agreementsm
12/34/56
EX-1.1
from 10-Q 39 pages Open Market Sale Agreementsm
12/34/56
EX-1
from SC 13G/A 2 pages Joint Filing Statement Pursuant to Rule 13d-1
12/34/56
EX-1.1
from 8-K 42 pages 4,000,000 Shares Arrowhead Pharmaceuticals, Inc. Underwriting Agreement
12/34/56
EX-1
from SC 13G/A 2 pages Joint Filing Statement Pursuant to Rule 13d-1
12/34/56
EX-1
from SC 13G 2 pages Joint Filing Statement Pursuant to Rule 13d-1
12/34/56
EX-1.1
from 8-K 39 pages 10,000,000 Shares Arrowhead Pharmaceuticals, Inc. Underwriting Agreement
12/34/56
EX-1
from SC 13D/A ~5 pages Joint Filing Agreement
12/34/56
EX-1
from SC 13D ~1 page Joint Filing Agreement
12/34/56
EX-1.1
from 8-K 40 pages 5,500,000 Shares Arrowhead Research Corporation Underwriting Agreement
12/34/56
EX-1
from SC 13G/A 1 page Exhibit 1 Joint Filing Agreement
12/34/56
EX-1.2
from 8-K 2 pages Strictly Confidential Christopher Anzalone, PH.D. Chief Executive Officer Arrowhead Research Corporation 225 South Lake Avenue, Suite 1050 Pasadena, California 91101 Dear Mr. Anzalone
12/34/56
EX-1.1
from 8-K 10 pages Strictly Confidential Arrowhead Research Corporation 225 South Lake Avenue, Suite 1050 Pasadena, Ca 91101 Attn: Christopher Anzalone PH.D. Dear Dr. Anzalone
12/34/56
EX-1.1
from 8-K 10 pages Strictly Confidential Arrowhead Research Corporation 225 South Lake Avenue, Suite 1050 Pasadena, Ca 91101 Attn: Christopher Anzalone PH.D. Dear Dr. Anzalone
12/34/56